Chief Technology Officer (Cto)
CurrentI joined Micrima in October 2021 to lead the development of a ground breaking product based on the technology which Micrima has been developing over the past 20 years. Our mission is to make a significant impact in early breast cancer detection, helping clinicians to detect more instances of breast cancer earlier. During this journey, we developed a revolutionary measurement device that uses non-ionizing radio waves. This device can be used in any location and by any user with just 30 minutes of training. It enables the measurement of breast tissue composition in both healthcare and community settings, even by community members where preferred. This innovation unlocks the potential for personalized breast cancer pathways, driving screening based on individual risk rather than general statistics. It also ensures patients receive the most appropriate imaging technique for their specific breast tissue type, improving first-time detection rates.I establish product development, operational, regulatory, and quality strategies, working closely with the team to deliver on these goals. In order to fulfil our vision for both customers and shareholders.